Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
| ▸ | ENPEP | Q07075 | 9/20 | 0.33 |
| ▸ | ANPEP | P15144 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2675600 | 0.84 | PTGS1 (0.46) | PTGS1SLC7A11ENPEPANPEP | |
| SCHEMBL22331155 | 0.84 | PTGS1 (0.46) | PTGS1SLC7A11ENPEPANPEP | |
| SCHEMBL22331154 | 0.84 | PTGS1 (0.46) | PTGS1SLC7A11ENPEPANPEP | |
| SCHEMBL107697 | 0.84 | PTGS1 (0.46) | PTGS1SLC7A11ENPEPANPEP | |
| Hydrochloric Acid SCHEMBL8378787 | 0.82 | PTGS1 (0.44) | PTGS1SLC7A11ENPEPANPEP | |
| Hydrochloric Acid SCHEMBL22331153 | 0.82 | PTGS1 (0.44) | PTGS1SLC7A11ENPEPANPEP | |
| SCHEMBL111371 | 0.82 | PTGS1 (0.44) | PTGS1SLC7A11ENPEP | |
| SCHEMBL111370 | 0.82 | PTGS1 (0.44) | PTGS1SLC7A11ENPEP | |
| SCHEMBL2675999 | 0.82 | PTGS1 (0.44) | PTGS1SLC7A11ENPEPANPEP | |
| SCHEMBL4255969 | 0.81 | CHRM1 (0.48) | PTGS1SLC7A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112615005-A | Method for preparing lithium iron phosphate anode composite material with good electrochemical performance based on waste bagasse | 桂林理工大学 | 2021-04-06 | — | — | CN | claimed |
| US-20040248765-A1 | Tumour targeting prodrugs activated by metallo matrixproteinases | COURT OF NAPIER UNIVERSITY, THE (GB) | 2004-12-09 | — | — | US | claimed |
| EP-1366064-A1 | TUMOUR TARGETING PRODRUGS ACTIVATED BY METALLO MATRIXPROTEINASES | The Court of Napier University (GB) | 2003-12-03 | — | — | EP | claimed |
| WO-2002072620-A1 | TUMOUR TARGETING PRODRUGS ACTIVATED BY METALLO MATRIXPROTEINASES | THE COURT OF NAPIER UNIVERSITY (GB) | 2002-09-19 | — | — | WO | claimed |
| CN-112615005-A | Method for preparing lithium iron phosphate anode composite material with good electrochemical performance based on waste bagasse | 桂林理工大学 | 2021-04-06 | — | — | CN | disclosed |
| US-20040248765-A1 | Tumour targeting prodrugs activated by metallo matrixproteinases | COURT OF NAPIER UNIVERSITY, THE (GB) | 2004-12-09 | — | — | US | disclosed |
| EP-1366064-A1 | TUMOUR TARGETING PRODRUGS ACTIVATED BY METALLO MATRIXPROTEINASES | The Court of Napier University (GB) | 2003-12-03 | — | — | EP | disclosed |
| CN-1458846-A | Synthetic erythropoiesis stimulating protein | GRYPHON THERPAEUTIC CO (US) | 2003-11-26 | — | — | CN | disclosed |
| WO-2002072620-A1 | TUMOUR TARGETING PRODRUGS ACTIVATED BY METALLO MATRIXPROTEINASES | THE COURT OF NAPIER UNIVERSITY (GB) | 2002-09-19 | — | — | WO | disclosed |
| EP-0871733-A2 | CLONED PORPHYROMONAS GINGIVALIS GENES AND PROBES FOR THE DETECTION OF PERIODONTAL DISEASE | UNIVERSITY OF FLORIDA (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1996017936-A2 | CLONED PORPHYROMONAS GINGIVALIS GENES AND PROBES FOR THE DETECTION OF PERIODONTAL DISEASE | UNIVERSITY OF FLORIDA (US) | 1996-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248765-A1 | Tumour targeting prodrugs activated by metallo matrixproteinases | MMP2, MMP26, ADAM17 | PTGS1 727/4885SLC7A11 3501/4885ENPEP 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.